482 related articles for article (PubMed ID: 30260049)
1. Cancer-associated fibroblasts: Secretions, interactions, and therapy.
Farhood B; Najafi M; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2791-2800. PubMed ID: 30260049
[TBL] [Abstract][Full Text] [Related]
2. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
Najafi M; Farhood B; Mortezaee K
J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
[TBL] [Abstract][Full Text] [Related]
3. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
[TBL] [Abstract][Full Text] [Related]
4. Cancer associated-fibroblast-derived exosomes in cancer progression.
Li C; Teixeira AF; Zhu HJ; Ten Dijke P
Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
6. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
Patel AK; Singh S
Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
Sazeides C; Le A
Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
[TBL] [Abstract][Full Text] [Related]
8. Stromal reprogramming: A target for tumor therapy.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Dec; 239():117049. PubMed ID: 31730862
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martinez-Zubiaurre I; Hellevik T
Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
[TBL] [Abstract][Full Text] [Related]
10. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
Piper M; Mueller AC; Karam SD
Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
[TBL] [Abstract][Full Text] [Related]
11. Cancer associated fibroblasts: is the force the path to the dark side?
Barbazán J; Matic Vignjevic D
Curr Opin Cell Biol; 2019 Feb; 56():71-79. PubMed ID: 30308331
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.
Wu F; Yang J; Liu J; Wang Y; Mu J; Zeng Q; Deng S; Zhou H
Signal Transduct Target Ther; 2021 Jun; 6(1):218. PubMed ID: 34108441
[TBL] [Abstract][Full Text] [Related]
14. Targeting Metabolic Cross Talk between Cancer Cells and Cancer-Associated Fibroblasts.
Jung JG; Le A
Adv Exp Med Biol; 2018; 1063():167-178. PubMed ID: 29946783
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
Zhu Y; Li X; Wang L; Hong X; Yang J
Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
[TBL] [Abstract][Full Text] [Related]
16. [Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
Huang C; Xu J; Li Z
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):267-273. PubMed ID: 32316714
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Guo S; Yuan J; Meng X; Feng X; Ma D; Han Y; Li K
Int Immunopharmacol; 2023 Sep; 122():110601. PubMed ID: 37418988
[TBL] [Abstract][Full Text] [Related]
18. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts: key determinants of tumor immunity and immunotherapy.
Barrett R; Puré E
Curr Opin Immunol; 2020 Jun; 64():80-87. PubMed ID: 32402828
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment: Interactions and therapy.
Najafi M; Goradel NH; Farhood B; Salehi E; Solhjoo S; Toolee H; Kharazinejad E; Mortezaee K
J Cell Physiol; 2019 May; 234(5):5700-5721. PubMed ID: 30378106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
